5-amino-1mq human clinical trials 5-Amino-1MQ NNMT Inhibitor Tablets
Description
[DOI] [PMC free article] [PubMed] [Google Scholar]
rare but serious reactions include anaphylaxis and hypokalaemia during initial treatment
Unexpectedly, subjects receiving CNTF in clinical trials for this indication experienced weight losses of 10--15%, prompting researchers to consider using CNTF to treat obesity [71]
Consistency daily injections without skipping days
Sekhar RV, Patel SG, Guthikonda AP, Reid M, Balasubramanyam A, Taffet GE, Jahoor F
For non-Medicare beneficiaries, an insurance waiver is needed
